Auto-generated event page
MAIA Biotechnology Announces Closing of $30 Million Underwritten Public Offering of Common Stock
Financing included participation by healthcare-dedicated investors alongside existing shareholders
Score 41
low confidence
1 source posts
Updated Mar 4, 2026, 9:06 PM UTC